This document assesses the risk to human health posed by a multi-country foodborne outbreak of Shiga toxin-producing Escherichia coli (STEC) infections associated with haemolytic uraemic syndrome taking place in the European Union (EU).
ECDC and EFSA have assessed the risk to the EU/EEA posed by a fatal human case of Bacillus anthracis infection in Bulgaria and concluded that this event represents a negligible risk to other EU/EEA countries.
This is an update to the joint rapid risk assessment published on 6 July 2012 by ECDC and EMCDDA on anthrax cases among injecting drug users in Germany. This is in response to further cases in France and Denmark. It contains information updated up to the 13 July 2012.
This is an update to the joint rapid risk assessment published on 22 June 2012 by ECDC and EMCDDA on anthrax cases among injecting drug users in Germany. This is in response to a third case in Berlin. It contains information updated up to the 6 July 2012.
This document is an update of the EFSA/ECDC joint rapid risk assessment of 29 June and aims to add new information to this and earlier initial rapid risk assessments (27 May and 14 June 2011).
An update of the initial rapid risk assessment on the outbreak of E. Coli in Germany, prepared at the request of the European Commission, first published on 27 May 2011.
Shiga toxin-producing E. coli (STEC) is a group of pathogenic Escherichia coli strains capable of producing Shiga toxins, with the potential to cause severe enteric and systemic disease in humans.
At the request of the European Commission’s Directorate-General for Health and Consumers, a rapid risk assessment has been prepared concerning the outbreak of E Coli in Germany.